Endometrial Cancer Treatment Market March 2017 Report Id : REP-GB-2834 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: [email protected] ©2015 Future Market Insights, All Rights Reserved 2 Research Methodology (1/2) Systematic Research Approach 1 Market profiling 2 Formulating discussion guide 3 Developing list of respondents 4 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Data collection PMR conducts interviews with industry experts, industry players, distributors and retailers Data validation Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 6 Data analysis Insights 7 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF) Data Collection Research & Intelligence Data Filter & Analysis Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Actionable Insights A Primary Research B SOLUTION Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments Primary Research # Linkedin Zoominfo Salesforce Avention Business Solution Desk Research C Key industry experts Channel study Developments Market dynamics Products Conclusions Company Analysis Secondary Research # Company websites Company annual reports White papers Financial reports Paid Publications# Factiva GBI Genios Meltwater # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3 Endometrial Cancer Treatment Market Analysis Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial cancers are typically diagnosed as type I and type II tumors and majority of the patients diagnosed with endometrial cancer represent early-stage cancers. According to Yale University School of Medicine, U.S., in 2014, type I tumors constitute 80% of all cases of endometrial cancers diagnosed in the U.S. Endometrial cancer can be treated by one or combination of chemotherapy, radiation therapy and hormone therapy. Most of the physicians recommend combination treatments as chemotherapy alone has traditionally been deem ineffective. Adjuvant radiation therapy is preferred in patients who have diagnosed with sage I or II endometrial cancer. Radiation therapy is also recommended in patients who have undergone the surgery, in order to avoid the relapse of endometrial cancer. Endometrial cancer is often detected in women above the age of 50 years and risk of endometrial cancer increases with the age. Also the risk of development of endometrial cancer is more in breast cancer patients who are being treated with tamoxifen or estrogen for long time. Plenty of chemotherapeutic agents are available and are recommended in the combination for the treatment of endometrial cancer. Some of the combination therapies include carboplatin & paclitaxel, Cisplatin & doxorubicin, Carboplatin & docetaxel and others. Endometrial Cancer Treatment Market: Drivers and Restraints Increasing incidence of uterine serous carcinoma – a highly aggressive variant of endometrial cancer – and relapse of endometrial cancers in patients treated with chemotherapy are the prime factors driving the growth of global endometrial cancer treatment market over the forecast period. In 2014, uterine serous carcinoma represented 10% of all caseload of endometrial cancers in the U.S. ©2015 Future Market Insights, All Rights Reserved 4 Endometrial Cancer Treatment Market Analysis Some of the risk factors of endometrial cancer include obesity, presence of polycystic ovarian syndrome, long-term consumption of birth control pills, delayed pregnancy etc. Increasing incidence of obesity in the women aged above 50 can lead to the growth of endometrial cancer treatment market. However, divergent nature of cancer and increasing stringency in the regulatory requirements are the prime factors limiting the growth of global endometrial cancer treatment market. Besides this, side effects related to chemotherapy, radiation therapy and hormone therapy also restricts the adoption of these agents for endometrial cancer treatment. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2834 Endometrial Cancer Treatment Market: Segmentation The global endometrial cancer treatment market has been segmented on the basis of treatment type, end user, and geography. Based on treatment type, the global endometrial cancer treatment market is divided into following: Chemotherapy Carboplatin Paclitaxel ©2015 Future Market Insights, All Rights Reserved 5 Endometrial Cancer Treatment Market Analysis Ixabepilone Others Hormonal Therapy Megestrol (Megace) Medroxyprogesterone (PROVERA) Others (anastrozole, letrozole, etc.) Radiation Therapy Whole Pelvic External-beam Radiation Therapy Vaginal Brachytherapy Surgery Hysterectomy Bilateral Salpingo-oophorectomy (removal of both fallopian tubes and ovaries) ©2015 Future Market Insights, All Rights Reserved 6 Endometrial Cancer Treatment Market Analysis Based on end user, the global endometrial cancer treatment market is segmented as below: Retail Pharmacy Hospital pharmacy Clinics Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2834 Endometrial Cancer Treatment Market: Overview Global market for endometrial cancer treatment is forecast to grow at moderate rate owing to less number of drugs approved for treatment of endometrial cancer. Despite of this, chemotherapy segment is expected to hold the highest share in the global endometrial cancer treatment market due to high adoption rate of chemotherapy over radiation and surgical treatment. Also chemotherapeutic agents such as carboplatin and paclitaxel are recommended as a first line of therapy in majority of the cases, which increases demand for these products. Recent FDA approval of IXEMPRA (ixabepilone) for use in the treatment of endometrial cancer treatment is expected to fuel the growth of global market over the forecast period. ©2015 Future Market Insights, All Rights Reserved 7 Endometrial Cancer Treatment Market Analysis Endometrial Cancer Treatment Market: Regional Wise Outlook Geographically, the global endometrial cancer treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America will continue to hold largest share in the global endometrial cancer treatment market due to high incidence of uterine serous carcinoma. Europe is expected to hold the second largest share in the global market partly due to increasing product availability in the region. North America is expected to expand at the highest rate over the forecast period. Full Report Analysis@ http://www.futuremarketinsights.com/reports/endometrial-cancer-treatmentmarket Endometrial Cancer Treatment Market: Key Players Some of the players operating in the global endometrial cancer treatment market include R-Pharm-US LLC., Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca Plc., Novartis AG and others. The global endometrial cancer treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research. ©2015 Future Market Insights, All Rights Reserved 8 To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: [email protected] For media queries, contact the press office at [email protected] For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: [email protected] Thank You Future Market Insights Global & Consulting Private Limited (FMI) ©2015 Future Market Insights, All Rights Reserved 9
Future Market Insights has announced the addition of the “Endometrial Cancer Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
© Copyright 2024 Paperzz
